(Q40864867)

24 September 2017

Anticoagulation to prevent stroke in atrial fibrillation and its implications for managed care (English)

1 reference

24 September 2017

1 reference

1 reference

D E Singer

1

1 reference

PubMed ID

9525571

24 September 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

American Journal of Cardiology

24 September 2017

1 reference

24 September 2017

81

1 reference

24 September 2017

35C-40C

1 reference

24 September 2017

5A

1 reference

Treatment of chronic atrial fibrillation.

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

Stroke Prevention in Atrial Fibrillation Study. Final results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

Canadian atrial fibrillation anticoaguiation (CAFA) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

Hypertension in the elderly. Implications and generalizability of randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

A differential effect of aspirin on prevention of stroke in atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

Optimal oral anticoagulant therapy in patients with mechanical heart valves.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

Risk factors for intracranial hemorrhage in outpatients taking warfarin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

Aging and the anticoagulant response to warfarin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

Cost effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

Long-term patient self-management of oral anticoagulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

Overview of the randomized trials to prevent stroke in atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900185-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(98)00185-4

1 reference

release_qvradzo2f5ao3d4xzwsnqak3ee

24 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qvradzo2f5ao3d4xzwsnqak3ee

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

9525571

1 reference

PubMed ID

9525571